"Somos, há 21 anos, a referência em tratamento oncológico no Norte-Nordeste. No nosso histórico, trazemos a visão centrada no paciente, o atendimento integral e uma Linha de Cuidado exclusiva como a expressão do nosso compromisso de entregar sempre as melhores soluções em saúde para os nossos clientes. Na trilha do Hospital do Câncer, crescemos como Hospital Haroldo Juaçaba e continuamos nossa história ampliando nossas frentes de operação e oferecendo ao público mais de 30 especialidades clínicas e gerais."

During the past decade, Instituto do Cancer do Ceara - ICC conducted 14 clinical trials. In the 10-year time frame, 14 clinical trials started and 4 clinical trials were completed, i.e. on average, 28.6% percent of trials that started reached the finish line to date. In the past 5 years, 10 clinical trials started and 4 clinical trials were completed. i.e. 40% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Instituto do Cancer do Ceara - ICC" #1 sponsor was "Eli Lilly and Company" with 3 trials, followed by "Janssen Research & Development, LLC" with 3 trials sponsored, "Clovis Oncology, Inc." with 2 trials sponsored, "Telik" with 2 trials sponsored and "Bayer" with 2 trials sponsored. Other sponsors include 2 different institutions and companies that sponsored additional 12 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Instituto do Cancer do Ceara - ICC" #1 collaborator was "AstraZeneca" with 1 trials as a collaborator, "BeiGene, Ltd." with 1 trials as a collaborator, "Bristol-Myers Squibb" with 1 trials as a collaborator, "Eisai Europe Ltd. (United Kingdom)" with 1 trials as a collaborator and "Foundation Medicine" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 8 trials.

According to Clinical.Site data, the most researched conditions in "Instituto do Cancer do Ceara - ICC" are "Ovarian Cancer" (3 trials), "Epithelial Ovarian Cancer" (2 trials), "Fallopian Tube Cancer" (2 trials), "Non-small Cell Lung Cancer" (2 trials) and "Peritoneal Cancer" (2 trials). Many other conditions were trialed in "Instituto do Cancer do Ceara - ICC" in a lesser frequency.

Most popular intervention types in "Instituto do Cancer do Ceara - ICC" are "Drug" (18 trials), "Biological" (1 trials) and "Diagnostic Test" (1 trials). Other intervention types were less common.

The name of intervention was led by "Abemaciclib" (2 trials), "Lenalidomide" (2 trials), "Rucaparib" (2 trials), "5-Fluorouracil" (1 trials) and "Abiraterone" (1 trials). Other intervention names were less common.

The vast majority of trials in "Instituto do Cancer do Ceara - ICC" are 11 trials for "All" genders, 4 trials for "Male" genders and 3 trials for "Female" genders.

Currently, there are NaN active trials in "Instituto do Cancer do Ceara - ICC". undefined are not yet recruiting, 9 are recruiting, 2 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 3 completed trials in Instituto do Cancer do Ceara - ICC, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Instituto do Cancer do Ceara - ICC, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 16 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".